ENDLOS-TURBO PUT - BIOGEN IDEC | Real-time Boerse Frankfurt Warrants 09:04:52 2024-06-28 EDT | ||
| 3.71 EUR | +0.54% |
|
| Current month | -8.89% | ||
| 1 month | -19.61% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 3.71 | +0.54% |
| 24-06-27 | 3.69 | -12.14% |
| 24-06-26 | 4.2 | -1.18% |
| 24-06-25 | 4.25 | +8.42% |
| 24-06-24 | 3.92 | -6.67% |
Real-time Boerse Frankfurt Warrants
Last update June 28, 2024 at 09:04 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ8BSW |
| ISIN | DE000DJ8BSW2 |
| Date issued | 2024-01-10 |
| Strike | 265.7 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.588 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 7.35 € |
|---|---|
| Lowest since issue | 1.03 € |
| Spread | 0.06 € |
| Spread % | 1.59% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
228.7
USD
Average target price
283.2
USD
Spread / Average Target
+23.80%
- Stock Market
- Certificates
- Certificat
